Major industrial order delive

RNS Number : 0005M
Surgical Innovations Group PLC
17 May 2010


Press Release

17 May 2010



Surgical Innovations Group plc

("SI" or "the Group")


Surgical Innovations delivers major industrial order


Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative surgical devices, is pleased to announce that it has now delivered the £616,000 order to one of its key industrial partners.  The order, originally due for completion in December 2009, was delayed as a consequence of third party technical difficulties, which were resolved in March 2010. This is the largest single order the Group has received within its industrial division.


Graham Bowland, Chief Executive Officer of Surgical Innovations, said: "Fulfilling this order represents an important step for our industrial division and we are delighted that a commercially successful outcome has arisen from the eighteen month development project.  We look forward to continuing development of the industrial business as we strive to develop the technology for a wider range of applications within the field."


- Ends -


For further information:

Surgical Innovations Group plc

Doug Liversidge, Chairman

Tel: +44 (0) 113 230 7597

Graham Bowland, Chief Executive Officer

Tel: +44 (0) 113 230 7597


Westhouse Securities Limited

Tim Feather / Matthew Johnson

Tel: +44 (0) 113 246 2611



Media enquiries:

Abchurch Communications

Sarah Hollins / Simone Elviss

Tel: +44 (0) 20 7398 7728


Notes to Editors:

About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery and industrial markets.  The Group has two divisions; Surgical Innovations Limited and Haemocell Limited.


The Group employs over 100 people at its 32,000 square feet facility in Leeds, with in-house design and the manufacturing of products to the highest quality standards.  Through an established network of 45 distribution partners, SI sells in all major medical markets including North America, Europe, South Africa, the Middle East, South-East Asia and Australia.


Surgical Innovations Limited, the main trading subsidiary of the Group, is focused on developing medical instruments for the laparoscopic surgery market - minimally invasive surgery of the abdomen.  The Group has pioneered Resposable® instrumentation combining both single use and reusable components ensuring an ongoing revenue stream and delivering the optimum procedure performance to cost ratio.  The Group's products include:



A Resposable® laparoscopic port access system that combines both single-use and reusable components


Resposable® laparoscopic instrumentation that combines both single-use and reusable components


single-use instruments, with an ergonomic handle to ensure accurate control of the instrument. The range includes scissors, graspers and dissectors


In addition to its own branded instruments, the Group also designs and manufactures devices on an OEM basis for large medical device companies including Teleflex Medical, Gyrus, Olympus and CareFusion.


For more information, see

This information is provided by RNS
The company news service from the London Stock Exchange
UK 100

Latest directors dealings